Zobrazeno 1 - 10
of 88
pro vyhledávání: '"SATAVAPTAN"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Deleuran, T, Watson, H, Vilstrup, H & Jepsen, P 2022, ' Risk Factors for Hepatic Hydrothorax in Cirrhosis Patients with Ascites-A Clinical Cohort Study ', Digestive Diseases and Sciences, vol. 67, no. 7, pp. 3395–3401 . https://doi.org/10.1007/s10620-021-07134-8
Deleuran, T, Watson, H, Vilstrup, H & Jepsen, P 2022, ' Risk Factors for Hepatic Hydrothorax in Cirrhosis Patients with Ascites-A Clinical Cohort Study ', Digestive Diseases and Sciences, vol. 67, no. 7, pp. 3395-3401 . https://doi.org/10.1007/s10620-021-07134-8
Deleuran, T, Watson, H, Vilstrup, H & Jepsen, P 2022, ' Risk Factors for Hepatic Hydrothorax in Cirrhosis Patients with Ascites-A Clinical Cohort Study ', Digestive Diseases and Sciences, vol. 67, no. 7, pp. 3395-3401 . https://doi.org/10.1007/s10620-021-07134-8
BACKGROUND: The risk factors for hepatic hydrothorax are unknown.METHODS: We used data from three randomized trials of satavaptan treatment in patients with cirrhosis and ascites followed for up to 1 year. We excluded patients with previous hepatic h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35af4784ee574b8329cb7ab886e66c6a
https://vbn.aau.dk/da/publications/b6de2ccf-fa69-45ba-85c2-ca74356cf4f9
https://vbn.aau.dk/da/publications/b6de2ccf-fa69-45ba-85c2-ca74356cf4f9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rajiv Jalan, Stewart Macdonald, Laith Alrubaiy, Hugh Watson, Hendrik Vilstrup, Peter Uhd Jepsen
Publikováno v:
Macdonald, S, Jepsen, P, Alrubaiy, L, Watson, H, Vilstrup, H & Jalan, R 2019, ' Quality of life measures predict mortality in patients with cirrhosis and severe ascites ', Alimentary Pharmacology and Therapeutics, vol. 49, no. 3, pp. 321-330 . https://doi.org/10.1111/apt.15084
Background: Severe ascites is associated with both a poor health-related quality of life (HRQL) and a mortality in excess of that captured by current prognostic clinical scores. Aim: To determine the association between HRQL and mortality in patients
Publikováno v:
Tetrahedron. 74:6485-6496
Application of radical cross-dehydrogenative coupling (CDC) procedures to prepare a range of novel spirocyclic oxindoles and to a formal total synthesis of the vasopressin V2 receptor antagonist Satavaptan is reported. The key step involves a copper-
Autor:
Alison Shaw, Alessandro Peri, Iain Cranston, Rachael McCool, Julie Glanville, Karl O'Reilly, Sunil Bhandari, Larisa Petrakova
Publikováno v:
Clinical Endocrinology. 86:761-771
International and national guidelines on the treatment of chronic nonhypovolaemic hypotonic hyponatraemia differ; therefore, we have undertaken this systematic review and meta-analysis to investigate the efficacy and safety of interventions for the t
Publikováno v:
Bossen, L, Ginès, P, Vilstrup, H, Watson, H & Jepsen, P 2019, ' Serum sodium as a risk factor for hepatic encephalopathy in patients with cirrhosis and ascites ', Journal of Gastroenterology and Hepatology, vol. 34, no. 5, pp. 914-920 . https://doi.org/10.1111/jgh.14558
Background and Aim: Hyponatremia is associated with development of hepatic encephalopathy (HE), but the nature of the relationship between serum sodium and HE incidence is unknown. We examined the association between serum sodium, changes in serum so
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78fe1be2d165fa6ea84d3cb4f77cf06d
https://pure.au.dk/portal/da/publications/serum-sodium-as-a-risk-factor-for-hepatic-encephalopathy-in-patients-with-cirrhosis-and-ascites(cf2c40a2-7677-4f14-b8f4-8cf2f926dadc).html
https://pure.au.dk/portal/da/publications/serum-sodium-as-a-risk-factor-for-hepatic-encephalopathy-in-patients-with-cirrhosis-and-ascites(cf2c40a2-7677-4f14-b8f4-8cf2f926dadc).html
Publikováno v:
Watson, H, Guevara, M, Vilstrup, H & Ginès, P 2019, ' Improvement of hyponatremia in cirrhosis is associated with improved complex information processing ', Journal of Gastroenterology and Hepatology, vol. 34, no. 11, pp. 1999-2003 . https://doi.org/10.1111/jgh.14683
BACKGROUND AND AIM: Hyponatremia, a cause of brain dysfunction and risk factor for hepatic encephalopathy, is frequent in patients with advanced cirrhosis and ascites. The interdependence of liver failure and hyponatremia makes it difficult to separa
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Current Hepatology Reports. 15:53-59
Hyponatremia is a common complication of patients with advanced cirrhosis that is associated with increased morbidity and mortality. Patients with cirrhosis may develop two types of hyponatremia: hypovolemic or hypervolemic hyponatremia. Hypervolemic